Last edition
News about Industrial talks
Zydus Lifesciences Hit by Legal Setback in U.S. Over Cancer Biosimilar Patent Dispute
While Zydus may consider appealing the verdict or negotiating a settlement, the setback highlights the broader challenges biosimilar manufacturers face in penetrating regulated markets like the U.S.
Industrial talks | 21/07/2025 | By Darshana | 387
PHARMEXCIL Chairman Urges Antimicrobial Drug Makers to Adopt Responsible Manufacturing Practices
Namit Joshi, Chairman of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), has warned that Antimicrobial Resistance (AMR) poses a serious threat to the industry's top line and urged manufacturers of antimicrobial products to make responsible manufacturing a core value rather than just a compliance checkbox.
Industrial talks | 21/07/2025 | By Dineshwori | 266
Sanofi Completes Acquisition of Blueprint Medicines, Expands Rare Immunology Portfolio
This strategic acquisition brings Sanofi a commercialised treatment, a promising pipeline, and deep scientific expertise in SM and related diseases. It also enhances Sanofi’s footprint across allergy, dermatology, and immunology specialities, bolstering its expanding immunology pipeline.
Industrial talks | 19/07/2025 | By Darshana | 282
With over 4,900 pharmaceutical colleges in India, many students remain underrepresented in mainstream pharma innovation. This initiative seeks to provide a structured platform for emerging student researchers to contribute to industry growth and national healthcare goals.
Industrial talks | 17/07/2025 | By Darshana | 149
New ESG Framework Aims to Transform Pharma Sector's Sustainability Metrics
Key ESG risks highlighted for pharma include climate vulnerabilities, energy consumption, workforce burnout, and data governance gaps—issues laid bare during the pandemic. However, the framework also underscores growth opportunities in digital health, ethical sourcing, green chemistry, and government-backed access programmes like Jan Aushadhi.
Industrial talks | 15/07/2025 | By Darshana | 290
Sun Pharma, Incyte Reach Settlement and License Agreement Over Leqselvi Manufacturing Rights
As part of the agreement, both parties will jointly move to dismiss the litigation pending in the United States District Court for the District of New Jersey. They have also agreed to mutually release all current and potential claims related to the case.
Industrial talks | 14/07/2025 | By Darshana | 268
ACG Engineering Appoints Nikhil Kulkarni as Group CEO to Drive Global Growth
ACG Engineering, the engineering arm of ACG Group, has appointed Nikhil Kulkarni as Group Chief Executive Officer. He will lead the division’s strategic direction and operations from ACG’s Pune headquarters, reporting directly to Karan Singh, Managing Director, ACG.
Industrial talks | 09/07/2025 | By Darshana | 237
SCRMP to host global conference on drug safety on August 23, 2025 at Indore
Media partner for this event is Pharmabiz, Pharma utility, Sanroj Infotech. This event aims to unite experts from the pharmaceutical industry, academia, regulatory authorities, and healthcare systems to foster global dialogue and innovation in pharmacovigilance and patient safety.
Industrial talks | 20/06/2025 | By Darshana | 231
This collaboration will bring cutting-edge imaging solutions such as MRI, CT, and PET-CT to underserved areas, significantly boosting early diagnosis and treatment efficiency.
Industrial talks | 19/06/2025 | By Darshana | 382
Medtronic to invest $50 million over 5 years in New Diabetes Global Capability Centre in Pune
For over four decades, the diabetes business has served people living with diabetes through groundbreaking innovations with the goal of improving outcomes and giving people the freedom to forget about their diabetes. This world-class, state-of-the-art centre in Pune, India will enable the company’s commitment to continue to fulfill this mission.
Industrial talks | 17/06/2025 | By Darshana | 305
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy